Janet K. Hess-Wilson

Application of Transcriptional Benchmark Dose Values in Quantitative Cancer and Noncancer Risk Assessment

Russell S. Thomas, Harvey J. Clewell, Bruce C. Allen et al. · Toxicological Sciences · 2010 · 139 citations

Chemoprevention Strategy, Cancer Management, Epidemiology Of Cancer +22

Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Response in Prostate Cancer Cells

Ankur Sharma, Clay E.S. Comstock, Erik S. Knudsen et al. · Cancer Research · 2007 · 88 citations · Full text

Urology, Oncology, Medicine +13

Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer

Yelena B. Wetherill, Janet K. Hess-Wilson, Clay E.S. Comstock et al. · Molecular Cancer Therapeutics · 2006 · 75 citations

Differences between Human and Rat Intestinal and Hepatic Bisphenol A Glucuronidation and the Influence of Alamethicin on In Vitro Kinetic Measurements

Christopher S. Mazur, John F. Kenneke, Janet K. Hess-Wilson et al. · Drug Metabolism and Disposition · 2010 · 61 citations

Application of computational toxicological approaches in human health risk assessment. I. A tiered surrogate approach

Nina Ching Yi Wang, Qin Zhao, Scott C. Wesselkamper et al. · Regulatory Toxicology and Pharmacology · 2012 · 41 citations

Human Safety Assessment, Computational Toxicological Approaches, Predictive Toxicology +12